We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
A task force of the U.S. Food and Drug Administration (FDA), in conjunction with the Obama Administration’s Open Government initiative, recently released 21 draft proposals that would broaden FDA’s public disclosure policies
